Zanetti: We've spoken about Icardi too much

Inter vice-president Javier Zanetti said there has been too much talk about Mauro Icardi amid uncertainty over the star's future in Milan. Icardi has not played since he was stripped of the captaincy last month, with the disgruntled striker claiming to have been injured but Inter initially said tests could not uncover a specific issue. Linked with the likes of Real Madrid, Juventus and Napoli amid a contract stand-off, Icardi returned to Inter training on Tuesday. Asked if Icardi could be in line to face Lazio in Serie A action on Sunday, Zanetti said: "I think we have talked about him too much. "Now we must focus on the field because it is fundamental for the season finale." Inter are third in Serie A, two points clear of fourth-placed AC Milan following their derby victory prior to the international break. Zanetti added: "We have the goal of qualifying for the Champions League, 10 games are left and on Sunday we meet a direct rival. The team is preparing...

Here Comes That GMO Flu Shot

"Getting a flu shot is a personal choice, although most healthcare experts recommend it. But now there's a new vaccine in town. You know that flu vaccine you're hearing about? The one that's made using an insect virus? About 150,000 doses of FluBlok are expected to hit the market at the tail end of the 2013 flu season. The Food and Drug Administration (FDA) approved the vaccine for use for 18- to 49-year-olds, saying it is different than other flu vaccines on the market because it isn't grown using eggs. This allows for much faster manufacturing. The approval came after a clinical trial of 2,300 people found FluBlok prevented the flu in about 45 percent of cases and was effective against all circulating flu viruses, not just the strains included in the vaccine.
According to Protein Sciences Corporation, the Connecticut-based manufacturer, Flublok does not contain the controversial mercury-containing preservative thimerosal. "This approval represents a technological advance in the manufacturing of an influenza vaccine," says Karen Midthun, MD, director of the FDA's Center for Biologics Evaluation and Research. "The new technology offers the potential for faster startup of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the influenza virus."
SOURCE: RODALE 
How do they know, how do they know it is safe, where are the studies?

And, ONLY 45% effective.  Not much to say for this jab, better to try to improve your nutrition and take good herbs, supplements, foods - all that are know to be of help.


Comments

Popular posts from this blog

Important New Reading

VITAMINS HAVE NEVER KILLED ANYONE

Zanetti: We've spoken about Icardi too much